Clinical Study for Recurrent Prostate Cancer

Have you previously had surgery to treat prostate cancer, but think the cancer has returned? Has your doctor recommended radiation therapy as the next step in your care?

A voluntary research study is being conducted to help men with recurring prostate cancer by using advanced imaging technology called FACBC to guide radiotherapy and determine the best possible course of treatment. This study would be added as an extra layer in your ongoing cancer treatment.

Participants must meet specific eligibility criteria:

  • You are over 18 years of age.
  • You had surgery (prostatectomy) to treat your prostate cancer.
  • Your doctor suspects that the cancer has returned (as indicated by a rising PSA).
  • Radiation therapy is now being considered as the next step in your care.

The trial is open at several convenient Emory locations: Emory University Hospital, Emory University Hospital Midtown, Emory Saint Joseph's Hospital and Grady Memorial Hospital.

Please note:You will be followed for a minimum of three years, with PSA levels checked every six months, in addition to having study-related lab work. There is no cost for the FACBC scan or the Food & Drug Administration (FDA) required lab work. All other imaging, lab work, biopsies (if any), radiation therapy and any other therapy will be billed to your insurance provider or paid out of pocket by you. You may be eligible for a travel voucher if you are chosen to undergo the FACBC scan.

For more information or to check your eligibility, please ask your provider or call Ashesh Jani, MD, at (404) 778-3827 or email abjani@emory.edu.

Cascade Link   TOP